Category Archives: Press Release

BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers

BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s [...]

01
Jul
BioReference Laboratories Supports Man Cave Health During National Men’s Health Month

Complimentary PSA Testing Provided to Participants of Annual Golf Tournament ELMWOOD PARK, N.J., June 7 – [...]

07
Jun
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch [...]

17
May
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories
January 7, 2019

Geoff Monk promoted to President MIAMI, Jan. 07, 2019 – OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment [...]

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.
November 8, 2018

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory [...]

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
May 18, 2018

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local [...]

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
May 1, 2018

MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager [...]

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
March 16, 2018

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can [...]

OPKO Health Announces Leadership Changes at BioReference Laboratories
January 26, 2018

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from [...]

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center
January 12, 2018

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference [...]